Intravenous Administration of Metoprolol Versus Biatrial Pacing in the Prevention of Atrial Fibrillation After Cardiac Surgery
Information source: Kuopio University Hospital
Information obtained from ClinicalTrials.gov on October 19, 2009
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Atrial Fibrillation; Biatrial Pacing; Metoprolol
Intervention: metoprolol, biatrial pacing (Other)
Phase: Phase 4
Status: Recruiting
Sponsored by: Kuopio University Hospital Overall contact:
Jari Halonen, MD, Phone: +358405885829, Email: jari.halonen@kuh.fi
Summary
The aim of the study is to compare the effectiviness of biatrial pacing versus intravenous
administration of metoprolol in the prevention of atrial fibrillation after cardiac surgery
Clinical Details
Official title: Intravenous Metoprolol Versus Biatrial Pacing in the Prevention of Atrial Fibrillation After Cardiac Surgery
Study design: Prevention, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Primary outcome: biatriac pacingIncidence of atrial fibrillation
Eligibility
Minimum age: N/A.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- elective CABG and aortic valve cardiac patients,
- previous use of beta blocker
Exclusion Criteria:
- Previous episodes of Atrial fibrillation or flutter,
- II or II degree atrioventricular block, uncontrolled heart failure
- Sick sinus syndrome
Locations and Contacts
Jari Halonen, MD, Phone: +358405885829, Email: jari.halonen@kuh.fi
Halonen Jari, Kuopio FIN-70211, Finland; Recruiting
Jari Halonen, MD, Phone: +358405885829, Email: jari.halonen@kuh.fi
Jari Halonen, MD, Principal Investigator
Additional Information
Starting date: January 2007
Ending date: June 2010
Last updated: August 10, 2009
|
